Skip to Content
Merck
CN

28-5240

Strontium chloride hexahydrate

JIS special grade, ≥99.0%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
SrCl2 · 6H2O
CAS Number:
Molecular Weight:
266.62
UNSPSC Code:
12352302
PubChem Substance ID:
EC Number:
233-971-6
MDL number:
Assay:
≥99.0%
Grade:
JIS special grade
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

JIS special grade

assay

≥99.0%

form

solid

availability

available only in Japan

mp

115 °C (lit.)

SMILES string

O.O.O.O.O.O.Cl[Sr]Cl

InChI

1S/2ClH.6H2O.Sr/h2*1H;6*1H2;/q;;;;;;;;+2/p-2

InChI key

AMGRXJSJSONEEG-UHFFFAOYSA-L



Still not finding the right product?

Explore all of our products under Strontium chloride hexahydrate


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1

Storage Class

11 - Combustible Solids

wgk

WGK 1

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Salil Vengalil et al.
Current opinion in supportive and palliative care, 6(3), 310-315 (2012-06-20)
Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of
Bernhard Pemmer et al.
Journal of synchrotron radiation, 18(Pt 6), 835-841 (2011-10-15)
Based on clinical trials showing the efficacy to reduce vertebral and non-vertebral fractures, strontium ranelate (SrR) has been approved in several countries for the treatment of postmenopausal osteoporosis. Hence, it is of special clinical interest to elucidate how the Sr
Diane Cummins
American journal of dentistry, 23 Spec No A, 3A-13A (2011-02-03)
To provide a brief overview of the diagnosis, epidemiology, etiology and clinical management of dentin hypersensitivity, to discuss technical approaches to relieve sensitivity, with special emphasis on dentin tubule occlusion and the clinical evidence for efficacy of desensitizing toothpastes based